San Diego, CA, United States of America

Jianghuai Xu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jianghuai Xu: Innovator in Angiogenic Therapies

Introduction

Jianghuai Xu is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the development of therapies targeting angiogenic diseases. With a total of 3 patents, his work focuses on innovative compounds and antibodies that have the potential to transform treatment options for various cancers and eye diseases.

Latest Patents

One of Jianghuai Xu's latest patents involves VEGFA/Ang2 Compounds. This invention relates to compounds that bind to human vascular endothelial growth factor A (VEGFA) and human angiopoietin-2 (Ang2). These compounds may be useful for treating angiogenic eye diseases, such as diabetic and other proliferative retinopathies, as well as for cancer, particularly solid tumors driven by VEGFA and Ang2, including gastric, lung, hepatocellular carcinoma, ovarian, colorectal, and breast cancers. Another significant patent is for Ang2 antibodies, which bind to human angiopoietin-2 (Ang2). These antibodies may be beneficial for treating cancer, both alone and in combination with VEGF pathway inhibitors, especially in cancers driven by VEGFR2 and Ang2.

Career Highlights

Jianghuai Xu is currently associated with Eli Lilly and Company, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in oncology and ophthalmology.

Collaborations

Jianghuai Xu collaborates with several talented individuals in his field, including Donmienne Doen Mun Leung and Ying Tang. These collaborations enhance the innovative potential of his research and contribute to the advancement of medical science.

Conclusion

Jianghuai Xu is a dedicated inventor whose work in angiogenic therapies holds promise for improving treatment outcomes in cancer and eye diseases. His innovative patents reflect a commitment to advancing medical research and providing new solutions for challenging health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…